BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1645359)

  • 1. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
    Lappi DA; Maher PA; Martineau D; Baird A
    J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
    Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
    Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
    J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
    McDonald JR; Ong M; Shen C; Parandoosh Z; Sosnowski B; Bussell S; Houston LL
    Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
    Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
    Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin.
    Lappi DA; Matsunami R; Martineau D; Baird A
    Anal Biochem; 1993 Aug; 212(2):446-51. PubMed ID: 8214586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic effect of the mitotoxin bFGF-saporin on bovine lens epithelial cell growth: effect of cell density and extracellular matrix.
    David T; Tassin J; Lappi DA; Baird A; Courtois Y
    J Cell Physiol; 1992 Dec; 153(3):483-90. PubMed ID: 1447311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
    Ying W; Martineau D; Beitz J; Lappi DA; Baird A
    Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and chemical characterization of basic FGF-saporin mitotoxin.
    Lappi DA; Martineau D; Baird A
    Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of virion penetration into vascular cells by association of basic fibroblast growth factor with herpes simplex virus type 1.
    Baird A; Florkiewicz RZ; Maher PA; Kaner RJ; Hajjar DP
    Nature; 1990 Nov; 348(6299):344-6. PubMed ID: 2174511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
    Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
    Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evidence for FGF-1 control of blastema cell proliferation during limb regeneration of the amphibian Pleurodeles waltl.
    Zenjari C; Boilly-Marer Y; Desbiens X; Oudghir M; Hondermarck H; Boilly B
    Int J Dev Biol; 1996 Oct; 40(5):965-71. PubMed ID: 8946244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local infusion of FGF-saporin reduces intimal hyperplasia.
    Mattar SG; Hanson SR; Pierce GF; Chen C; Hughes JD; Cook JE; Shen C; Noe BA; Suwyn CR; Scott JR; Lumsden AB
    J Surg Res; 1996 Feb; 60(2):339-44. PubMed ID: 8598665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus infection enhances killing of melanoma cells by a mitotoxin.
    Satyamoorthy K; Soballe PW; Soans F; Herlyn M
    Cancer Res; 1997 May; 57(10):1873-6. PubMed ID: 9157978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
    Martineau D; Lappi DA; Amburn E; Baird A
    Ann N Y Acad Sci; 1991; 638():438-41. PubMed ID: 1785818
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model.
    Davol P; Frackelton AR
    J Urol; 1996 Sep; 156(3):1174-9. PubMed ID: 8709341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effects of FGF2-saporin on bovine epithelial lens cells in vitro.
    Behar-Cohen FF; David T; Buechler Y; Nova MP; Houston LL; Pouliquen YM; Courtois Y
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2425-33. PubMed ID: 7591632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.